Imaging manifestations of unusual side effects of new anticancer medications

por Parameswaran, B, Moodie, K
Publicado 2014

Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT

por Handolias, D, Hamilton, A L, Salemi, R, Tan, A, Moodie, K, Kerr, L, Dobrovic, A, McArthur, G A
Publicado 2010

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy

por Day, F L, Link, E, Ngan, S, Leong, T, Moodie, K, Lynch, C, Michael, M, Winton, E de, Hogg, A, Hicks, R J, Heriot, A
Publicado 2011